166 related articles for article (PubMed ID: 29230975)
1. Negative Pap tests in women with high-grade cervical lesions on follow-up biopsies: Contributing factors and role of human papillomavirus genotyping.
Goodman S; Mody RR; Coffey D; Gorman BK; Luna E; Armylagos D; Schwartz MR; Mody DR; Ge Y
Diagn Cytopathol; 2018 Mar; 46(3):239-243. PubMed ID: 29230975
[TBL] [Abstract][Full Text] [Related]
2. Atypical glandular cells in Pap tests: cytology-histology correlation and risk assessment with human papillopmavirus (HPV) testing.
Goetz LH; Evans HL; Armylagos D; Zhou H; Mody DR; Schwartz MR; Ge Y
J Am Soc Cytopathol; 2024; 13(3):227-232. PubMed ID: 38401997
[TBL] [Abstract][Full Text] [Related]
3. Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.
Shen-Gunther J; Wang CM; Poage GM; Lin CL; Perez L; Banks NA; Huang TH
Clin Epigenetics; 2016; 8(1):96. PubMed ID: 27651839
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness.
Kaufman RH; Adam E; Icenogle J; Reeves WC
Am J Obstet Gynecol; 1997 Oct; 177(4):930-6. PubMed ID: 9369847
[TBL] [Abstract][Full Text] [Related]
5. Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer.
Ge Y; Christensen P; Luna E; Armylagos D; Schwartz MR; Mody DR
Cancer Cytopathol; 2017 Aug; 125(8):652-657. PubMed ID: 28574670
[TBL] [Abstract][Full Text] [Related]
6. Discrepant HPV/cytology cotesting results: Are there differences between cytology-negative versus HPV-negative cervical intraepithelial neoplasia?
Tracht JM; Davis AD; Fasciano DN; Eltoum IA
Cancer Cytopathol; 2017 Oct; 125(10):795-805. PubMed ID: 28817235
[TBL] [Abstract][Full Text] [Related]
7. Reflex high-risk human papilloma virus DNA test is useful in the triage of women with atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion.
Wu HH; Allen SL; Kirkpatrick JL; Elsheikh TM
Diagn Cytopathol; 2006 Oct; 34(10):707-10. PubMed ID: 16955480
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results.
Bandyopadhyay S; Austin RM; Dabbs D; Zhao C
Arch Pathol Lab Med; 2008 Dec; 132(12):1874-81. PubMed ID: 19061283
[TBL] [Abstract][Full Text] [Related]
9. High-Risk Human Papillomavirus Testing, Genotyping, and Histopathologic Follow-up in Women With Abnormal Glandular Cells on Papanicolaou Tests.
Zuo T; Levi AW; Lin Q; Abi-Raad R; Adeniran AJ; Cai G
Am J Clin Pathol; 2021 Sep; 156(4):569-576. PubMed ID: 33728437
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
[No Abstract] [Full Text] [Related]
11. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.
Arbyn M; Buntinx F; Van Ranst M; Paraskevaidis E; Martin-Hirsch P; Dillner J
J Natl Cancer Inst; 2004 Feb; 96(4):280-93. PubMed ID: 14970277
[TBL] [Abstract][Full Text] [Related]
12. Rescreening of high-risk HPV positive Papanicolaou tests initially screened as negative is a low yield procedure in the era of HPV genotyping.
Narkcham S; Mody DR; Jones A; Thrall MJ
J Am Soc Cytopathol; 2021; 10(6):558-564. PubMed ID: 34103275
[TBL] [Abstract][Full Text] [Related]
13. Negative computer-imaged ThinPrep Pap test and positive hybrid capture2 HPV co-testing results: A quality assurance review.
Rao R; Molina D; Halligan AM; Vakil B; Alperstein SA; Hoda RS
Diagn Cytopathol; 2015 Sep; 43(9):763-9. PubMed ID: 26173579
[TBL] [Abstract][Full Text] [Related]
14. Reflex Human Papillomavirus Test Results as an Option for the Management of Korean Women With Atypical Squamous Cells Cannot Exclude High-Grade Squamous Intraepithelial Lesion.
Ryu KJ; Lee S; Min KJ; Kim JW; Hong JH; Song JY; Lee JK; Lee NW
Oncologist; 2015 Jun; 20(6):635-9. PubMed ID: 25964305
[TBL] [Abstract][Full Text] [Related]
15. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
16. Is the human papillomavirus test in combination with the Papanicolaou test useful for management of patients with diagnoses of atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions?
Lee NW; Kim D; Park JT; Kim A
Arch Pathol Lab Med; 2001 Nov; 125(11):1453-7. PubMed ID: 11698001
[TBL] [Abstract][Full Text] [Related]
17. Analytical performance of cervista HPV 16/18 in SurePath pap specimens.
Guo M; Khanna A; Feng J; Patel S; Zhang W; Gong Y; Huo L; Staerkel G
Diagn Cytopathol; 2015 Apr; 43(4):301-6. PubMed ID: 25352375
[TBL] [Abstract][Full Text] [Related]
18. Clinical performance of the Food and Drug Administration-Approved high-risk HPV test for the detection of high-grade cervicovaginal lesions.
Zhou H; Mody RR; Luna E; Armylagos D; Xu J; Schwartz MR; Mody DR; Ge Y
Cancer Cytopathol; 2016 May; 124(5):317-23. PubMed ID: 26774025
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of high-risk human papillomavirus in women with abnormal and normal vaginal ThinPrep Papanicolaou cytology.
Bansal M; Zhao C
J Low Genit Tract Dis; 2011 Apr; 15(2):105-9. PubMed ID: 21317806
[TBL] [Abstract][Full Text] [Related]
20. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]